The Infinium Global Research analyzes the Alzheimer’s Drugs Market over the period of 2018 to 2024. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global alzheimer’s drugs market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of alzheimer’s drugs. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the alzheimer’s drugs market during the period. The global Alzheimer’s drugs market is projected to grow at a CAGR of 7.0% over the forecast period of 2018-2024.
We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.
The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1357
Alzheimer’s disease is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. Cholinesterase inhibitors are set to treat symptoms related to memory, language, thinking, judgment and other thought processes. The Alzheimer’s drugs prevent the breakdown of a chemical messenger in the brain. It is the cause of 60–70% of cases of dementia.
The cholinergic, memantine, combined drug and other drugs are used to treat the Alzheimer’s disease. The presence of high revenue-generating drugs such as Donepezil, Exelon, and galantamine is a key driver, for the growth of cholinergic drug. Memantine, the fifth Alzheimer’s drug, is an NMDA (N-methyl-D-aspartate) receptor antagonist has dominated the drug class segment due to large number of patent expiry of major products and a restricted number of drugs to treat Alzheimer’s disease.
Development of New Drugs and Therapies which Has Helped in the Development and Growth of the Alzheimer’s Drugs Market
The rising occurrence of neurodegenerative diseases among the elderly and a healthy support from governments across developed countries has led to the development of new drugs and therapies which has helped in the development and growth of the Alzheimer’s drugs market. Additionally, lack of Duchenne muscular dystrophy (DMD) is another factor that promotes the growth of the market. The lack of DMDs extends the treatment schedule for Alzheimer’s disease, which in turn, increases the healthcare costs for patients.
Get this Section as a Free Customization in the Report along with Discount on the Study: https://www.infiniumglobalresearch.com/reports/request-discount/1357
North America is Expected to the Largest Market for Alzheimer’s Drugs
Among the regions, North America is expected to the largest market for Alzheimer’s drugs. The large number of patients suffering from the Alzheimer’s disease, high purchasing power for expensive drugs and compensation policies for the treatment of this disease is likely to boost the growth in this market. The increasing awareness about neurodegenerative diseases in Asia Pacific region will boost the growth of the global Alzheimer’s drugs market in the next coming years.
Segmentation of the Alzheimer’s Drugs Industry
The report on global Alzheimer’s drugs market covers segments such as, drug class and distribution channel. On the basis of drug class, the global Alzheimer’s drugs market is categorized into cholinergic, memantine, combined drug and others. On the basis of distribution channel, the global Alzheimer’s drugs market is categorized into hospital pharmacy, retail pharmacy and online pharmacy.
Key Players in the Alzheimer’s Drugs Industry
The report provides profiles of the companies in the global Alzheimer’s drugs market such as, H Lundbeck A/S, Eisai Co Ltd, Ono Pharmaceutical, Daiichi Sankyo Company Limited, Johnson & Johnson, Merz Holding GmbH & Co KG and Others.
Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-alzheimers-drugs-market
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the Alzheimer’s drugs.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research– Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.